Adam Jansen, | |
8100 Northland Dr, Bloomington, MN 55431-4800 | |
(952) 831-8742 | |
Not Available |
Full Name | Adam Jansen |
---|---|
Gender | Male |
Speciality | Occupational Therapy |
Experience | 9 Years |
Location | 8100 Northland Dr, Bloomington, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821508433 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225XH1200X | Occupational Therapist - Hand | (* (Not Available)) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Tria Orthopaedic Center Llc | 3173570561 | 367 |
News Archive
Friends play an extremely important role in a person's life. From infancy on, we have a desire to connect and those early relationships help to mold and develop our adult character.
Study findings published in Acta Psychiatrica Scandinavica confirm that both genetics and environmental factors such as trauma independently influence the development and persistence of subthreshold psychotic symptoms.
A study based on a contemporary registry of patients with myocardial infarction (heart attack) indicates that even though hospitals that perform a higher number of angioplasties are more likely to follow evidence-based guidelines and have shorter times to the angioplasty procedure, there appears to be no significant difference in outcomes such as length of hospital stay or risk of death, according to a study in the November 25 issue of JAMA.
Organogenesis Inc., a global leader in advanced wound care innovations and technologies, today announced that its PuraPly and PuraPly Antimicrobial (AM) wound management products are now eligible for Medicare coverage and reimbursement in 10 states, providing coverage for an additional 7.5 million Medicare beneficiaries, following the decision by National Government Services (NGS) to retire its local coverage determination (LCD) for cellular and tissue-based products (CTPs) effective September 1, 2016.
Treatment with the anti-hypertensive drug valsartan (Diovan) led to a modest reduction in the development of type 2 diabetes but did not significantly reduce cardiovascular events in patients with impaired glucose tolerance, according to researchers at Duke University Medical Center and the University of Oxford. They jointly reported results at the American College of Cardiology meeting today from the world's first study designed to find ways to control the progression to diabetes and cardiovascular disease in people at risk.
› Verified 3 days ago
Provider Name | Tria Orthopaedic Center Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1518273085 PECOS PAC ID: 3173570561 Enrollment ID: O20110310000999 |
News Archive
Friends play an extremely important role in a person's life. From infancy on, we have a desire to connect and those early relationships help to mold and develop our adult character.
Study findings published in Acta Psychiatrica Scandinavica confirm that both genetics and environmental factors such as trauma independently influence the development and persistence of subthreshold psychotic symptoms.
A study based on a contemporary registry of patients with myocardial infarction (heart attack) indicates that even though hospitals that perform a higher number of angioplasties are more likely to follow evidence-based guidelines and have shorter times to the angioplasty procedure, there appears to be no significant difference in outcomes such as length of hospital stay or risk of death, according to a study in the November 25 issue of JAMA.
Organogenesis Inc., a global leader in advanced wound care innovations and technologies, today announced that its PuraPly and PuraPly Antimicrobial (AM) wound management products are now eligible for Medicare coverage and reimbursement in 10 states, providing coverage for an additional 7.5 million Medicare beneficiaries, following the decision by National Government Services (NGS) to retire its local coverage determination (LCD) for cellular and tissue-based products (CTPs) effective September 1, 2016.
Treatment with the anti-hypertensive drug valsartan (Diovan) led to a modest reduction in the development of type 2 diabetes but did not significantly reduce cardiovascular events in patients with impaired glucose tolerance, according to researchers at Duke University Medical Center and the University of Oxford. They jointly reported results at the American College of Cardiology meeting today from the world's first study designed to find ways to control the progression to diabetes and cardiovascular disease in people at risk.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Adam Jansen, 2657 Cristine Ct, White Bear Lake, MN 55110-5761 Ph: () - | Adam Jansen, 8100 Northland Dr, Bloomington, MN 55431-4800 Ph: (952) 831-8742 |
News Archive
Friends play an extremely important role in a person's life. From infancy on, we have a desire to connect and those early relationships help to mold and develop our adult character.
Study findings published in Acta Psychiatrica Scandinavica confirm that both genetics and environmental factors such as trauma independently influence the development and persistence of subthreshold psychotic symptoms.
A study based on a contemporary registry of patients with myocardial infarction (heart attack) indicates that even though hospitals that perform a higher number of angioplasties are more likely to follow evidence-based guidelines and have shorter times to the angioplasty procedure, there appears to be no significant difference in outcomes such as length of hospital stay or risk of death, according to a study in the November 25 issue of JAMA.
Organogenesis Inc., a global leader in advanced wound care innovations and technologies, today announced that its PuraPly and PuraPly Antimicrobial (AM) wound management products are now eligible for Medicare coverage and reimbursement in 10 states, providing coverage for an additional 7.5 million Medicare beneficiaries, following the decision by National Government Services (NGS) to retire its local coverage determination (LCD) for cellular and tissue-based products (CTPs) effective September 1, 2016.
Treatment with the anti-hypertensive drug valsartan (Diovan) led to a modest reduction in the development of type 2 diabetes but did not significantly reduce cardiovascular events in patients with impaired glucose tolerance, according to researchers at Duke University Medical Center and the University of Oxford. They jointly reported results at the American College of Cardiology meeting today from the world's first study designed to find ways to control the progression to diabetes and cardiovascular disease in people at risk.
› Verified 3 days ago
Christina Jean Jensen, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 4801 W 81st St Ste 112, Bloomington, MN 55437 Phone: 952-345-3000 Fax: 952-345-6789 | |
Ms. Sandra Marie Meyer, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3800 American Blvd W, The Hartford, Bloomington, MN 55431 Phone: 952-656-6321 | |
Kim M Waterbury, MS, OTRL, CHT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 8100 Northland Dr, Bloomington, MN 55431 Phone: 952-831-8742 | |
Bailey Paige O'connell, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1801 American Blvd E, Bloomington, MN 55425 Phone: 952-767-2267 | |
Ms. Nancy J Callinan, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 8100 Northland Dr, Bloomington, MN 55431 Phone: 952-831-8742 | |
Jennifer Shana Voorhees, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 900 West 94th Street, Bloomington, MN 55420 Phone: 952-885-0418 Fax: 952-885-0173 | |
Anna Kate Restemayer, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4801 W 81st St Ste 112, Bloomington, MN 55437 Phone: 952-345-3000 Fax: 952-345-6789 |